R26-CAG-LSL-RSR-tdTomato-2A-DTR

Nomenclature

C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-LSL-RSR-tdTomato-2A-DTR)Smoc

Cat. NO.

NM-KI-190086

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Gt(ROSA)26Sor

Model Description

These mice harbor a CAG-LSL-RSR-tdTomato-2A-DTR cassette in the Rosa26 locus generated by homologous recombination.
Research Application:Dre and Dre reporter

Validation Data

image.png

Fig1. Immunostaining for tdTomato on sections of multiple tissues or organs collected from ACTB-Cre;R26-LR-tdT-DTR mice (upper panel) or CAG-Dre;R26-LR-tdT-DTR mice (lower panel). 

image.png

Fig2. DTR-mediated cardiomyocyte ablation after DT administration. 

A, a schematic figure showing experimental design. B, whole-mount view of triple transgenic mice treated with PBS or DT. Yellow scale bar represents 2000 μm.  C, immunostaining for DTR and tdTomato on heart sections of triple transgenic mice. White scale bar represents100 μm.  D, immunostaining for cTnT and tdTomato on heart sections of triple transgenic mice. White scale bar represents 100 μm. E, immunostaining for Tunel and tdTomato on heart sections. White scale bar represents 100 μm.

image.png

Fig3. DTR-mediated specific ablation of Cyp2e1+ peri-central hepatocytes.

A, a cartoon figure showing the mouse’s mating strategy. B, whole-mount epifluorescence view of livers collected from mice treated with DT or PBS. Yellow scale bar represents 2000 μm.  C and D, immunostaining for tdTomato, HNF4a (E), or DTR (F) on liver sections treated with PBS. White scale bar represents 100 μm. C, central vein. E, immunostaining for CYP2E1, tdTomato, and E-cad on liver sections from mice treated with PBS or DT. White scale bar represents 100 μm. F, quantification of the percentage of tdTomato+ hepatocytes (DT group) in comparison of tdTomato+ hepatocytes (PBS group). G, immunostaining for Tunel and tdTomato on liver sections from mice treated with PBS or DT. White scale barrepresents 100 μm.

image.png

Fig4. DTR-mediated specific ablation of Mfsd2a+ peri-portal hepatocytes.

A, a schematic figure showing the genetic recombination of the R26-LR-tdT-DTR allele by Mfsd2a-CreER and AAV8-TBG-Dre.  B, whole-mount fluorescent view of livers collected from mice treated with PBS or DT. Yellow scale bar represents 2000 μm.  C and D, immunostaining for tdTomato, HNF4a (E), or DTR (F) on liver sections of mice treated with PBS.White scale bar represents100 μm. E, immunostainingfor E-cad and tdTomato on liver sections from mice treated with PBS or DT. White scale bar represents 100 μm.  F, quantification of the percentage of tdTomato+ hepatocytes (DT group) in comparison with tdTomato+ hepatocytes (PBS group). n = 5.  G, immunostaining for Tunnel and tdTomato on liver sections of mice treated with PBS or DT. White scale bar represents 100 μm.

*The above data is derived from: Wang H, He L, Li Y, et al. Dual Cre and Dre recombinases mediate synchronized lineage tracing and cell subset ablation in vivo. J Biol Chem. 2022;298(6):101965. doi:10.1016/j.jbc.2022.101965



You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more